Analytical Data
-
Gene name
ADSL
- Application
-
Alternative Names
ADSL；AMPS；Adenylosuccinate lyase
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P30566
-
Expression Region
1-484aa
-
AA Sequence
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDRWGSMAAGGDHGSPDSYR SPLASRYASPEMCFVFSDRYKFRTWRQLWLWLAEAEQTLGLPITDEQIQE MKSNLENIDFKMAAEEEKRLRHDVMAHVHTFGHCCPKAAGIIHLGATSCY VGDNTDLIILRNALDLLLPKLARVISRLADFAKERASLPTLGFTHFQPAQ LTTVGKRCCLWIQDLCMDLQNLKRVRDDLRFRGVKGTTGTQASFLQLFEG DDHKVEQLDKMVTEKAGFKRAFIITGQTYTRKVDIEVLSVLASLGASVHK ICTDIRLLANLKEMEEPFEKQQIGSSAMPYKRNPMRSERCCSLARHLMTL VMDPLQTASVQWFERTLDDSANRRICLAEAFLTADTILNTLQNISEGLVV YPKVIERRIRQELPFMATENIIMAMVKAGGSRQDCHEKIRVLSQQAASVV KQEGGDNDLIERIQVDAYFSPIHSQLDHLLDPSSFTGRASQQVQRFLEEE VYPLLKPYESVMKVKAELCL
-
Molecular Weight
59 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ADSL (Adenylosuccinate lyase) is an essential enzyme involved in the purine nucleotide metabolism pathway, specifically in the de novo synthesis of adenine and guanine nucleotides. Mutations in the ADSL gene can lead to ADSL deficiency, a rare genetic disorder associated with severe neurological symptoms, including developmental delays, seizures, and autistic features. Research into ADSL has gained momentum as scientists seek to understand the enzyme's structure, function, and role in cellular metabolism. Advances in structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, have allowed researchers to elucidate the three-dimensional structure of ADSL, providing insights into its catalytic mechanisms and substrate binding. Furthermore, understanding the molecular basis of ADSL deficiency paves the way for potential therapeutic approaches, including gene therapy and substrate replacement strategies. The continued exploration of ADSL and its associated pathways is crucial for developing effective treatments for patients affected by this debilitating condition, as well as for understanding broader aspects of nucleotide metabolism and its implications in various diseases.
